Torsemide
Brand name: Torsemide
Rank #401 of 500 drugs by total cost
$22.2M
Total Cost
971,579
Total Claims
$22.2M
Total Cost
25,503
Prescribers
$23
Cost per Claim
208,548
Beneficiaries
1,823,146
30-Day Fills
$871
Avg Cost/Provider
38
Avg Claims/Provider
About Torsemide
Torsemide (sold as Torsemide) was prescribed 971,579 times by 25,503 Medicare Part D providers in 2023, costing the program $22.2M. At $23 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 398 | Roflumilast (Roflumilast) | $22.8M | 97,022 |
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology